Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Cantor Fitzgerald
- EF Hutton
- Maxim Group
- Aegis Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for VolitionRX
What is the target price for VolitionRX (VNRX)?
The latest price target for VolitionRX (AMEX: VNRX) was reported by Cantor Fitzgerald on August 16, 2023. The analyst firm set a price target for $2.00 expecting VNRX to rise to within 12 months (a possible 190.28% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VolitionRX (VNRX)?
The latest analyst rating for VolitionRX (AMEX: VNRX) was provided by Cantor Fitzgerald, and VolitionRX maintained their overweight rating.
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
Is the Analyst Rating VolitionRX (VNRX) correct?
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a maintained with a price target of $3.00 to $2.00. The current price VolitionRX (VNRX) is trading at is $0.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.